NFKB1 and stroke disorder: Clinical studies further indicate that Ditan Decoction inhibits NF-κB and miR-146a expression in serum, which correlates with reduced neuroinflammatory responses and improved neurological function scores in PSD patient post-stroke (Luo W. et al., 2019).